190 related articles for article (PubMed ID: 15010188)
1. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease.
Kafali H; Iriadam M; Ozardali I; Demir N
Arch Med Res; 2004; 35(2):103-8. PubMed ID: 15010188
[TBL] [Abstract][Full Text] [Related]
2. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat.
Baravalle C; Salvetti NR; Mira GA; Pezzone N; Ortega HH
Arch Med Res; 2006 Oct; 37(7):830-9. PubMed ID: 16971221
[TBL] [Abstract][Full Text] [Related]
3. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat.
Zurvarra FM; Salvetti NR; Mason JI; Velazquez MM; Alfaro NS; Ortega HH
Reprod Fertil Dev; 2009; 21(7):827-39. PubMed ID: 19698287
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
Mitwally MF; Casper RF
J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
[TBL] [Abstract][Full Text] [Related]
5. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.
Maliqueo M; Sun M; Johansson J; Benrick A; Labrie F; Svensson H; Lönn M; Duleba AJ; Stener-Victorin E
Endocrinology; 2013 Jan; 154(1):434-45. PubMed ID: 23183180
[TBL] [Abstract][Full Text] [Related]
6. Induction of Stein-Leventhal-like polycystic ovaries (PCO) in the rat: a new model for cystic ovarian disease.
McCarthy GF; Brawer JR
Anat Rec; 1990 Oct; 228(2):137-44. PubMed ID: 2122768
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.
Rezvanfar MA; Rezvanfar MA; Ahmadi A; Saadi HA; Baeeri M; Abdollahi M
Hum Exp Toxicol; 2012 Sep; 31(9):887-97. PubMed ID: 22076494
[TBL] [Abstract][Full Text] [Related]
8. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
9. The effects of metformin and letrozole on endometrium and ovary in a rat model.
Oner G; Ozcelik B; Ozgun MT; Ozturk F
Gynecol Endocrinol; 2011 Dec; 27(12):1084-6. PubMed ID: 21770833
[TBL] [Abstract][Full Text] [Related]
10. Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.
Cao SF; Hu WL; Wu MM; Jiang LY
Reprod Sci; 2017 Mar; 24(3):456-462. PubMed ID: 27407136
[TBL] [Abstract][Full Text] [Related]
11. Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat.
Pandey V; Singh A; Singh A; Krishna A; Pandey U; Tripathi YB
Reprod Biol; 2016 Mar; 16(1):70-7. PubMed ID: 26952756
[TBL] [Abstract][Full Text] [Related]
12. Endocrine sex reversal of gonads by the aromatase inhibitor Letrozole (CGS 20267) in Emys orbicularis, a turtle with temperature-dependent sex determination.
Richard-Mercier N; Dorizzi M; Desvages G; Girondot M; Pieau C
Gen Comp Endocrinol; 1995 Dec; 100(3):314-26. PubMed ID: 8775058
[TBL] [Abstract][Full Text] [Related]
13. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
Elnashar A; Fouad H; Eldosoky M; Saeid N
Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
[TBL] [Abstract][Full Text] [Related]
14. Extraovarian gonadotropin negative feedback revealed by aromatase inhibition in female marmoset monkeys.
Kraynak M; Flowers MT; Shapiro RA; Kapoor A; Levine JE; Abbott DH
Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E507-E514. PubMed ID: 28679622
[TBL] [Abstract][Full Text] [Related]
15. A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activity.
Wood PM; Woo LW; Humphreys A; Chander SK; Purohit A; Reed MJ; Potter BV
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):123-30. PubMed ID: 15862957
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
17. The effect of cold stress on polycystic ovary syndrome in rat: before and during modeling.
Zangeneh FZ; Abdollahi A; Tavassoli P; Naghizadeh MM
Arch Gynecol Obstet; 2011 Sep; 284(3):651-7. PubMed ID: 20949356
[TBL] [Abstract][Full Text] [Related]
18. The ovary retains male potential after the thermosensitive period for sex determination in the turtle Emys orbicularis.
Dorizzi M; Richard-Mercier N; Pieau C
Differentiation; 1996 Jul; 60(4):193-201. PubMed ID: 8765049
[TBL] [Abstract][Full Text] [Related]
19. Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
Kumru S; Yildiz AA; Yilmaz B; Sandal S; Gurates B
Gynecol Endocrinol; 2007 Oct; 23(10):556-61. PubMed ID: 17952760
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease.
Sohrabvand F; Ansari Sh; Bagheri M
Hum Reprod; 2006 Jun; 21(6):1432-5. PubMed ID: 16478764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
